Your account is not claimed yet. You can sign up with ORCID to claim your account.

Laura Conti

Scopus Author ID ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 23

Top Venues

Cancers

Nature communications

Biomedicines

Oncoimmunology

University of Turin

Università degli Studi di Torino (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Turin Dec 23o 2019

Italy

Assistant Professor (RTDb) :: Dept of Molecular Biotechnology and Health Science

Education History

Università degli Studi di Torino Oct 1o 2003 - Dec 7o 2007

Italy

PHD :: Dept. of Clinical and Biological Sciences

Publications

Vincenzo Salemme, Mauro Vedelago, Alessandro Sarcinella, Federico Moietta, Alessio Piccolantonio, Enrico Moiso, Giorgia Centonze, Marta Manco, Andrea Guala, Alessia Lamolinara, Costanza Angelini, Alessandro Morellato, Dora Natalini, Raffaele Adolfo Calogero, Danny Incarnato, Salvatore Oliviero, Laura Conti, Manuela Iezzi, Daniela Tosoni, Giovanni Bertalot, Stefano Freddi, Francesco A Tucci, Francesco De Sanctis, Cristina Frusteri, Stefano Ugel, Vincenzo Bronte, Federica Cavallo, Paolo Provero, Marta Gai, Daniela Taverna, Emilia Turco, Salvatore Pece, Paola Defilippi
p140Cap inhibits β-Catenin in the breast cancer stem cell compartment instructing a protective anti-tumor immune response. Nature communications 14 (1) (2023)
Vincenzo Salemme, Mauro Vedelago, Alessandro Sarcinella, Federico Moietta, Alessio Piccolantonio, Enrico Moiso, Giorgia Centonze, Marta Manco, Andrea Guala, Alessia Lamolinara, Costanza Angelini, Alessandro Morellato, Dora Natalini, Raffaele Adolfo Calogero, Danny Incarnato, Salvatore Oliviero, Laura Conti, Manuela Iezzi, Daniela Tosoni, Giovanni Bertalot, Stefano Freddi, Francesco A Tucci, Francesco De Sanctis, Cristina Frusteri, Stefano Ugel, Vincenzo Bronte, Federica Cavallo, Paolo Provero, Marta Gai, Daniela Taverna, Emilia Turco, Salvatore Pece, Paola Defilippi
p140Cap inhibits β-Catenin in the breast cancer stem cell compartment instructing a protective anti-tumor immune response. Nature communications 14 (1) (2023)
Vincenzo Salemme, Mauro Vedelago, Alessandro Sarcinella, Federico Moietta, Alessio Piccolantonio, Enrico Moiso, Giorgia Centonze, Marta Manco, Andrea Guala, Alessia Lamolinara, Costanza Angelini, Alessandro Morellato, Dora Natalini, Raffaele Adolfo Calogero, Danny Incarnato, Salvatore Oliviero, Laura Conti, Manuela Iezzi, Daniela Tosoni, Giovanni Bertalot, Stefano Freddi, Francesco A Tucci, Francesco De Sanctis, Cristina Frusteri, Stefano Ugel, Vincenzo Bronte, Federica Cavallo, Paolo Provero, Marta Gai, Daniela Taverna, Emilia Turco, Salvatore Pece, Paola Defilippi
p140Cap inhibits β-Catenin in the breast cancer stem cell compartment instructing a protective anti-tumor immune response. Nature communications 14 (1) (2023)
Vincenzo Salemme, Mauro Vedelago, Alessandro Sarcinella, Federico Moietta, Alessio Piccolantonio, Enrico Moiso, Giorgia Centonze, Marta Manco, Andrea Guala, Alessia Lamolinara, Costanza Angelini, Alessandro Morellato, Dora Natalini, Raffaele Adolfo Calogero, Danny Incarnato, Salvatore Oliviero, Laura Conti, Manuela Iezzi, Daniela Tosoni, Giovanni Bertalot, Stefano Freddi, Francesco A Tucci, Francesco De Sanctis, Cristina Frusteri, Stefano Ugel, Vincenzo Bronte, Federica Cavallo, Paolo Provero, Marta Gai, Daniela Taverna, Emilia Turco, Salvatore Pece, Paola Defilippi
p140Cap inhibits β-Catenin in the breast cancer stem cell compartment instructing a protective anti-tumor immune response. Nature communications 14 (1) (2023)
Federica Riccardo, Lidia Tarone, Mariateresa Camerino, Davide Giacobino, Selina Iussich, Giuseppina Barutello, Maddalena Arigoni, Laura Conti, Elisabetta Bolli, Elena Quaglino, Irene Fiore Merighi, Emanuela Morello, Alfredo Dentini, Soldano Ferrone, Paolo Buracco, Federica Cavallo
Antigen mimicry as an effective strategy to induce CSPG4-targeted immunity in dogs with oral melanoma: a veterinary trial. Journal for immunotherapy of cancer 10 (5) (2022)
Giuseppina Barutello, Antonino Di Lorenzo, Alessandro Gasparetto, Chiara Galiazzi, Elisabetta Bolli, Laura Conti, Federica Cavallo
Immunotherapy against the Cystine/Glutamate Antiporter xCT Improves the Efficacy of APR-246 in Preclinical Breast Cancer Models. Biomedicines 10 (11) (2022)
Martina Capozza, Rachele Stefania, Valentina Dinatale, Valeria Bitonto, Laura Conti, Cristina Grange, Renata Skovronova, Enzo Terreno
A Novel PSMA-Targeted Probe for NIRF-Guided Surgery and Photodynamic Therapy: Synthesis and Preclinical Validation. International journal of molecular sciences 23 (21) (2022)
Marco Macagno, Silvio Bandini, Elisabetta Bolli, Amanda Bello, Federica Riccardo, Giuseppina Barutello, Irene Fiore Merighi, Guido Forni, Alessia Lamolinara, Francesco Del Pizzo, Manuela Iezzi, Federica Cavallo, Laura Conti, Federica Cavallo
Role of ADCC, CDC, and CDCC in Vaccine-Mediated Protection against Her2 Mammary Carcinogenesis. Biomedicines 10 (2) (2022)
Junbiao Wang, Alessia Lamolinara, Laura Conti, Mara Giangrossi, Lishan Cui, Maria Beatrice Morelli, Consuelo Amantini, Maurizio Falconi, Caterina Bartolacci, Cristina Andreani, Fiorenza Orlando, Mauro Provinciali, Francesco Domenico Del Pizzo, Francesca Russo, Barbara Belletti, Federica Riccardo, Elisabetta Bolli, Federica Cavallo, Federica Cavallo, Augusto Amici, Manuela Iezzi, Cristina Marchini
HER2-Displaying M13 Bacteriophages induce Therapeutic Immunity against Breast Cancer. Cancers 14 (16) (2022)
Enza Di Gregorio, Chiara Romiti, Antonino Di Lorenzo, Federica Cavallo, Giuseppe Ferrauto, Laura Conti
RGD_PLGA Nanoparticles with Docetaxel: A Route for Improving Drug Efficiency and Reducing Toxicity in Breast Cancer Treatment. Cancers 15 (1) (2022)
Enza Di Gregorio, Chiara Romiti, Antonino Di Lorenzo, Federica Cavallo, Giuseppe Ferrauto, Laura Conti
RGD_PLGA Nanoparticles with Docetaxel: A Route for Improving Drug Efficiency and Reducing Toxicity in Breast Cancer Treatment. Cancers 15 (1) (2022)
Enza Di Gregorio, Chiara Romiti, Antonino Di Lorenzo, Federica Cavallo, Giuseppe Ferrauto, Laura Conti
RGD_PLGA Nanoparticles with Docetaxel: A Route for Improving Drug Efficiency and Reducing Toxicity in Breast Cancer Treatment. Cancers 15 (1) (2022)
Antonino Di Lorenzo, Elisabetta Bolli, Roberto Ruiu, Giuseppe Ferrauto, Enza Di Gregorio, Lidia Avalle, Aurora Savino, Pietro Poggio, Irene Fiore Merighi, Federica Riccardo, Mara Brancaccio, Federica Cavallo, Federica Cavallo, Laura Conti
Toll-like receptor 2 promotes breast cancer progression and resistance to chemotherapy. Oncoimmunology 11 (1) (2022)
Roberto Ruiu, Giuseppina Barutello, Maddalena Arigoni, Federica Riccardo, Laura Conti, Giulia Peppino, Laura Annaratone, Caterina Marchio, Giulio Mengozzi, Raffaele Adolfo Calogero, Federica Cavallo, Federica Cavallo
Identification of TENM4 as a Novel Cancer Stem Cell-Associated Molecule and Potential Target in Triple Negative Breast Cancer. Cancers 13 (4) (2021)
Laura Seclì, Lidia Avalle, Pietro Poggio, Giuseppe Fragale, Cristiana Cannata, Laura Conti, Andrea Iannucci, Giovanna Carrà, Cristina Rubinetto, Barbara Miniscalco, Emilio Hirsch, Valeria Poli, Alessandro Morotti, Marco De Andrea, Emilia Turco, Federica Cavallo, Federica Fusella, Mara Brancaccio
Targeting the Extracellular HSP90 Co-Chaperone Morgana Inhibits Cancer Cell Migration and Promotes Anticancer Immunity. Cancer research 81 (18) (2021)
Jolanda Magri, Alessandro Gasparetto, Laura Conti, Enzo Calautti, Chiara Cossu, Roberto Ruiu, Giuseppina Barutello, Federica Cavallo
Tumor-Associated Antigen xCT and Mutant-p53 as Molecular Targets for New Combinatorial Antitumor Strategies. Cells 10 (1) (2021)
Antonino Di Lorenzo, Elisabetta Bolli, Lidia Tarone, Federica Cavallo, Laura Conti
Toll-Like Receptor 2 at the Crossroad between Cancer Cells, the Immune System, and the Microbiota. International journal of molecular sciences 21 (24) (2020)
Federica Riccardo, Giuseppina Barutello, Angela Petito, Lidia Tarone, Laura Conti, Maddalena Arigoni, Chiara Musiu, Stefania Izzo, Marco Volante, Dario Livio Longo, Irene Fiore Merighi, Mauro Papotti, Federica Cavallo, Federica Cavallo
Immunization against ROS1 by DNA Electroporation Impairs K-Ras-Driven Lung Adenocarcinomas . Vaccines 8 (2) (2020)
Laura Conti, Elisabetta Bolli, Antonino Di Lorenzo, Valentina Franceschi, Francesca Macchi, Federica Riccardo, Roberto Ruiu, Luca Russo, Elena Quaglino, Gaetano Donofrio, Federica Cavallo
Immunotargeting of the xCT Cystine/Glutamate Antiporter Potentiates the Efficacy of HER2-Targeted Immunotherapies in Breast Cancer. Cancer immunology research 8 (8) (2020)
Annasofia Anemone, Lorena Consolino, Laura Conti, Pietro Irrera, Myriam Y Hsu, Daisy Villano, Walter Dastrù, Paolo Ettore Porporato, Federica Cavallo, Dario Livio Longo
Tumour acidosis evaluated in vivo by MRI-CEST pH imaging reveals breast cancer metastatic potential. British journal of cancer 124 (1) (2020)
Valeria Rolih, Jerri Caldeira, Elisabetta Bolli, Ahmad Salameh, Laura Conti, Giuseppina Barutello, Federica Riccardo, Jolanda Magri, Alessia Lamolinara, Karla Parra, Paloma Valenzuela, Giulio Francia, Manuela Iezzi, Federica Pericle, Federica Cavallo
Development of a VLP-Based Vaccine Displaying an xCT Extracellular Domain for the Treatment of Metastatic Breast Cancer. Cancers 12 (6) (2020)
Elvira Smeralda Famulari, Victor Navarro-Tableros, Maria Beatriz Herrera Sanchez, Giulia Bortolussi, Marta Gai, Laura Conti, Lorenzo Silengo, Emanuela Tolosano, Ciro Tetta, Andrés Fernando Muro, Giovanni Camussi, Sharmila Fagoonee, Fiorella Altruda
Human liver stem cells express UGT1A1 and improve phenotype of immunocompromised Crigler Najjar syndrome type I mice. Scientific reports 10 (1) (2020)
Gaetano Donofrio, Giulia Tebaldi, Stefania Lanzardo, Roberto Ruiu, Elisabetta Bolli, Andrea Ballatore, Valeria Rolih, Francesca Macchi, Laura Conti, Federica Cavallo
Bovine herpesvirus 4-based vector delivering the full length xCT DNA efficiently protects mice from mammary cancer metastases by targeting cancer stem cells. Oncoimmunology 7 (12) (2018)

Laura Conti.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Laura Conti